# Ophelia

> Ophelia is a New York-based telehealth company making evidence-based opioid use disorder (OUD) treatment available from home. It connects people to licensed clinicians for medication-assisted treatment (buprenorphine/Suboxone), with video visits, on-demand messaging, and care coordination, deliberately removing the friction and stigma of traditional rehab. Founded in 2019 by Zack Gray after he lost a loved one to an overdose, Ophelia focuses heavily on Medicaid and rural populations and has raised roughly $68 million, including a $50M Series B led by Tiger Global in 2021.

- **Founded:** 2019
- **Headquarters:** New York, New York, United States
- **Founders:** Zack Gray (Co-Founder & CEO), Mattan Griffel (Co-Founder), Dr. Arthur Robin Williams (Chief Medical Officer), Dr. Adam Bisaga (Senior Medical Director)
- **Team size:** ~360 employees
- **Products:** Medication-Assisted Treatment (MAT), Synchronous video visits, On-demand messaging & care coordination, Co-occurring care
- **Notable:** Pennsylvania's first virtual-first, statewide OUD Center of Excellence., 79% of patients retained in treatment at 180 days - more than 2x the national average., 85% of patients attend early follow-up visits - more than 5x the national average.

## Products & services

- **Medication-Assisted Treatment (MAT)** — Telehealth-based treatment for opioid use disorder using FDA-approved medication (buprenorphine/Suboxone) prescribed by licensed clinicians, with pickup at a local pharmacy when eligible.
- **Synchronous video visits** — Video-based telehealth appointments with addiction clinicians, with support available 7 days a week.
- **On-demand messaging & care coordination** — Between-visit messaging, urine drug screens, optional groups, and care coordination services.
- **Co-occurring care** — Treatment for commonly co-occurring psychiatric disorders such as depression and anxiety.

## Achievements

- Pennsylvania's first virtual-first, statewide OUD Center of Excellence.
- 79% of patients retained in treatment at 180 days - more than 2x the national average.
- 85% of patients attend early follow-up visits - more than 5x the national average.
- Peer-reviewed research showing in-network coverage raises 180-day retention from 48.1% to 72.3%.
- Raised ~$68M total, including a $50M Series B led by Tiger Global.
- Coverage reaching ~85 million American lives across Medicaid, Medicare and commercial insurers.

## Latest updates

- **2025-05** — Announced partnership with Brave Health; reports treating patients in 14 states with contracts covering ~85 million lives.
- **2024-10** — Expanded New Jersey Medicaid coverage with Horizon BCBS, UnitedHealthcare and Wellpoint, reaching 89% of NJ Medicaid patients.
- **2024** — Designated Pennsylvania's first virtual-oriented Opioid Use Disorder Center of Excellence.
- **2021-12** — Closed $50M Series B led by Tiger Global Management.

## Links

- Website: https://ophelia.com
- LinkedIn: https://www.linkedin.com/company/opheliahealth/
- Twitter/X: https://twitter.com/meetophelia
- Facebook: https://www.facebook.com/opheliahealth/

---

Profile page: https://yespress.io/ophelia
Published by YesPress — https://yespress.io
Last updated: 2026-06-07